Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 4.73 billion. The enterprise value is 4.74 billion.
| Market Cap | 4.73B |
| Enterprise Value | 4.74B |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 66.15% |
| Owned by Institutions (%) | 1.09% |
| Float | 73.29M |
Valuation Ratios
The trailing PE ratio is 13.45 and the forward PE ratio is 12.43. BKK:KLINIQ's PEG ratio is 1.27.
| PE Ratio | 13.45 |
| Forward PE | 12.43 |
| PS Ratio | 1.40 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | 17.72 |
| P/OCF Ratio | 8.50 |
| PEG Ratio | 1.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.92, with an EV/FCF ratio of 17.75.
| EV / Earnings | 13.48 |
| EV / Sales | 1.40 |
| EV / EBITDA | 6.92 |
| EV / EBIT | 10.36 |
| EV / FCF | 17.75 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.24 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 0.96 |
| Debt / FCF | 2.47 |
| Interest Coverage | 17.79 |
Financial Efficiency
Return on equity (ROE) is 21.40% and return on invested capital (ROIC) is 22.10%.
| Return on Equity (ROE) | 21.40% |
| Return on Assets (ROA) | 9.31% |
| Return on Invested Capital (ROIC) | 22.10% |
| Return on Capital Employed (ROCE) | 20.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 526 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.49 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 91.03 million in taxes.
| Income Tax | 91.03M |
| Effective Tax Rate | 20.55% |
Stock Price Statistics
The stock price has decreased by -21.82% in the last 52 weeks. The beta is 0.05, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -21.82% |
| 50-Day Moving Average | 21.70 |
| 200-Day Moving Average | 24.79 |
| Relative Strength Index (RSI) | 49.69 |
| Average Volume (20 Days) | 188,981 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.39 billion and earned 351.56 million in profits. Earnings per share was 1.60.
| Revenue | 3.39B |
| Gross Profit | 1.73B |
| Operating Income | 457.54M |
| Pretax Income | 443.04M |
| Net Income | 351.56M |
| EBITDA | 545.77M |
| EBIT | 457.54M |
| Earnings Per Share (EPS) | 1.60 |
Balance Sheet
The company has 658.37 million in cash and 659.74 million in debt, with a net cash position of -1.37 million or -0.01 per share.
| Cash & Cash Equivalents | 658.37M |
| Total Debt | 659.74M |
| Net Cash | -1.37M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 7.56 |
| Working Capital | 213.11M |
Cash Flow
In the last 12 months, operating cash flow was 556.15 million and capital expenditures -289.15 million, giving a free cash flow of 266.99 million.
| Operating Cash Flow | 556.15M |
| Capital Expenditures | -289.15M |
| Free Cash Flow | 266.99M |
| FCF Per Share | 1.21 |
Margins
Gross margin is 51.21%, with operating and profit margins of 13.51% and 10.38%.
| Gross Margin | 51.21% |
| Operating Margin | 13.51% |
| Pretax Margin | 13.08% |
| Profit Margin | 10.38% |
| EBITDA Margin | 16.12% |
| EBIT Margin | 13.51% |
| FCF Margin | 7.88% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 6.48%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 6.48% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 90.74% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.48% |
| Earnings Yield | 7.43% |
| FCF Yield | 5.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:KLINIQ has an Altman Z-Score of 4.31 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 6 |